Experic Secures Growth Capital Investment Led by 1315 Capital
Slice of Healthcare Team
11/01/2024
Key Highlights
- 1315 Capital leads investment to fuel Experic’s expansion in biopharmaceutical services.
- Investment to enhance manufacturing capabilities and support global growth.
- Experic’s unique expertise in low-dose powder handling and agile services to benefit biopharma industry demands.
Source: Business Wire
Notable Quotes
“ 1315 Capital's investment will empower Experic to continue delivering innovative solutions and white glove services that meet our clients’ needs while expanding our footprint in the global biopharma market. ”
David Wood, CEO and Chairman at Experic
“ We are excited to partner with Experic as they continue to expand their capabilities and global reach. ”
Matt Reber, Partner at 1315 Capital
